NKE arrives at its June 25 earnings release carrying the weight of a brutal prior quarter, a wall of analyst downgrades, and a rare signal from the options market: for once, traders are leaning bullish rather than defensive.
The options positioning is the standout anomaly. The put/call ratio has dropped to 0.67, roughly 1.7 standard deviations below its 20-day average of 0.70 — the lowest reading in the past year on a z-score basis. That means call demand is running unusually hot relative to recent norms, even as the stock trades near multi-year lows. The borrow market reinforces the picture of limited short conviction: availability is extremely loose at 972% — nearly ten shares available for every one already lent out — and borrowing costs have eased 9% over the past week to just 0.46%. Short interest, at 3.8% of the free float, has declined roughly 8% over the past month, retreating steadily from a June 1 peak. The shorts have been covering, not adding.
The analyst community tells a sharply different story. A wave of downgrades hit in April following Nike's last catastrophic print — Goldman Sachs, JP Morgan, and Piper Sandler all stripped their buy ratings simultaneously. Then on June 10, just before the current report, UBS cut its target from $54 to $50 and RBC Capital downgraded to Sector Perform, slashing its target from $70 to $50. The consensus now sits at Hold, with a mean target of $59.58 — implying roughly 32% upside from the current $45.20, a gap that reflects how far the stock has fallen rather than any near-term enthusiasm. Bears point to a genuine list of structural concerns: competition from smaller agile brands, stalled momentum in China, and a turnaround whose benefits are now unlikely to show in numbers before 2027. Bulls counter with brand durability, improving inventory discipline, and the prospect of a Capital Markets Day in fall 2026 acting as a potential re-rating catalyst.
The insider activity from April adds a notable counterpoint to the bearish analyst tide. CEO Elliott Hill purchased nearly $1 million of stock in mid-April around $42, joined by Lead Independent Director Tim Cook, who added $1.06 million at similar levels. Three separate directors bought in the same week — a clustering of insider conviction at the lows that stands out against the backdrop of Wall Street skepticism. More recent trades show two executives selling smaller amounts in June, but those appear routine and are dwarfed by the April buying.
The last earnings print delivered a -12.9% one-day move and a -16.7% five-day move — the sharpest negative reaction in recent memory. Thursday's report will test whether the new management team can demonstrate that the inventory clean-up and product reset are translating into stabilising revenue trends, or whether guidance for fiscal 2027 will force another reset in Street expectations.
See the live data behind this article on ORTEX.
Open NKE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
